French 3,000 metre steeplechase specialist Ophelie Claude-Boxberger, who tested positive for EPO in September, has pressed charges against her father-in-law for poisoning her, her lawyer said Tuesday.
Claude-Boxberger filed charges in her home town of Montbeliard in eastern France for an "attack on physical integrity by administration of harmful substances", Laurent Clauzon told AFP.
The 31-year-old has been under investigation by Paris prosecutors into offences under anti-doping and poisonous substances legislation following a report from the French anti-doping agency (AFLD).
Claude-Boxberger has persistently denied she knowingly took a doping substance. Alain Flaccus, her father-in-law and part of her coaching setup, admitted last month to having administered her an injection of the banned endurance-boosting drug EPO.
But a source close to the investigation has since called for "prudence" on Flaccus' claim, saying he might have made the choice to "sacrifice himself" as the only way for the athlete to escape a four-year ban.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
